Organon (OGN) last issued guidance on February 12, 2026 for fiscal year 2026. The company guided revenue in the range of $6.20B - $6.20B for the period.

Compared to prior guidance, Organon maintained its revenue forecast from a prior range of $6.20B - $6.25B.

Organon has issued 17 guidance updates between May 5, 2022 and February 12, 2026. During this period, the company raised its outlook 3 times and lowered it 3 times, providing investors with insight into management's evolving expectations.